Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The present study presents a protocol for immunohistochemistry (IHC) that can image specific antigens located on tissue sections and determine the relative expression level of a target protein or the distribution of target cells.

Abstract

Immunohistochemistry (IHC) is one of the most useful detection techniques in scientific research and clinical practice. IHC can give researchers a direct view of a target protein or target cells through bi-colored images of histological tissue sections from patients. Cell nuclei are stained with hematoxylin and target proteins are stained via the chromogenic reaction of 3,3',4,4'-Biphenyltetramine tetrahydrochloride (DAB) in classic IHC, which can show both the relative expression level of a target protein and its location within the tissue. The principle utilized in IHC is the specific binding between an antigen and an antibody, which partially guarantees the accuracy of the results. IHC is also widely used to study cell subsets because it can show the exact location of target cell subsets in organs or tissues. This can help us understand their effects and functional mechanisms. Clinical data suggest that T-cell surface glycoprotein CD8 (CD8)+ tumor-infiltrating lymphocytes (TILs) could serve as an indication of the effectiveness of anti-programmed cell death 1 (PD-1) / programmed cell death ligand 1 (PD-L1) therapy in patients with tumors; therefore, IHC staining of CD8 protein to evaluate the CD8+ TILs in tissue sections becomes very important. IHC has several advantages. Samples are more accessible and last for a long time in storage. The reagents and equipment have been commercialized for years. However, there are also limitations. Lymphocyte infiltration into tumors is a dynamic process, and the results of IHC only reflect the infiltration at one specific time point, and not the dynamic changes over time. This disadvantage partly inhibits its clinical application in tumor immunotherapy, which mostly depends on T cell infiltration into the tumor microenvironment.

Introduction

The presence of tumor-infiltrating lymphocytes (TILs) is considered to be associated with better clinical outcomes in different kinds of cancer1,2,3,4,5. T-cell surface glycoprotein CD8 (CD8)+ TILs are the most important effectors to prevent tumor development among all TILs6,7,8. The application of IHC can be used to help researchers and/or pathologists accurately observe the CD8+ TILs of individual patients. Asses....

Protocol

The Ethical Committee of the Seventh Affiliated Hospital, Sun Yat-sen University approved all experimental methods used in the study.

1. Preparation of the sample

  1. Immerse the fresh human tumor tissue (within 30 min after resection; cut into 2 cm x 2 cm x 0.3 cm) in 10% formalin for 24 h (at least 2 h). The volume of formalin should be at least ten times greater than that of the tissue.
  2. Set the program of the tissue processor as follows: 70% ethanol for 60 min, 80% ethanol.......

Representative Results

Successful immunohistochemical staining shows the CD8+ TILs in the tumor sections (bladder cancer). CD8 protein expression (the surface marker of CD8+ TILs) are defined and quantified using the brown signal in the image (Figure 1); the blue signal represents the cell nucleus. Meanwhile, the location of CD8+ TILs can be determined by observing the distribution of both the brown and blue signals (Figure 2). Figure 3 and Figure 4

Discussion

The presence of CD8+ TILs has been reported in different kind of tumors6,7,8. The retrieval of the antigen denatures the CD8 protein and exposes the antigen epitope. Binding of the anti-CD8 antibody and subsequent horseradish peroxidase-labeled secondary antibody are quite effective and the color development is well established. The results of CD8 IHC can help to provide a direct view of CD8+ TILs in the tumor microenvironment, .......

Acknowledgements

This study was supported by Research Project of Shenzhen Health Family Planning System (grant#: SZBC2018001), the Natural Science Foundation of China (grant#: 81772754), and the Natural Science Foundation of Guangdong Province (grant#: 2017A030308009).

....

Materials

NameCompanyCatalog NumberComments
Ammonium hydroxideGuangzhou Chemical Reagent Factory1336-21-6
Antibody Diluent, Background ReducingDAKOS302281
Blocking buffer SerotecBUF029
CD8, Rabbit Monoclonal AntibodyThermo ScientificRM-9116-S 
Citrate bufferMXB BiotechnologiesMVS-0066Antigen retrieval buffer, pH 6.0
DABMXB BiotechnologiesDAB-0031
EthanolGuangzhou Chemical Reagent Factory
FormalinXiuwei CommerceXW-RS-019
Goat anti-Rabbit IgG (H+L) Cross Adsorbed Secondary Antibody, HRP conjugate Thermo Scientific31462
HematoxylinXiuwei CommerceXW-RS-001
HydrochloricGuangzhou Chemical Reagent Factory7647-01-0
Hydrogen peroxideGuangzhou Chemical Reagent Factory7722-84-1
ParaffinLeica39601006
Phosphate-buffered saline(PBS) MXB BiotechnologiesPBS-0060pH 7.5
Pressure cookerSupor
ResinXiuwei CommerceXW-RS-005
Tissue processorLeica TP1020
XyleneGuangzhou Chemical Reagent Factory1330-20-7

References

  1. Galon, J., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313 (5795), 1960-1964 (2006).
  2. Hwang, W. T., Adams, S. F., Tahirovic, E., Hagemann, I. S., Coukos, G.

Explore More Articles

immunohistochemistryCD8 TILstumor immunotherapyproteinantigenantibody

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved